tradingkey.logo
tradingkey.logo
Search

Ionis announces positive topline results from pivotal study of zilganersen in Alexander disease

ReutersSep 22, 2025 11:04 AM
facebooktwitterlinkedin

- Ionis Pharmaceuticals Inc IONS.O:

  • IONIS ANNOUNCES POSITIVE TOPLINE RESULTS FROM PIVOTAL STUDY OF ZILGANERSEN IN ALEXANDER DISEASE

  • IONIS PHARMACEUTICALS INC - PLANS NDA SUBMISSION FOR ZILGANERSEN IN Q1 2026

  • IONIS PHARMACEUTICALS INC - ZILGANERSEN 50 MG SHOWS SIGNIFICANT STABILIZATION IN GAIT SPEED

  • IONIS PHARMACEUTICALS INC - ZILGANERSEN SHOWS BENEFIT IN SECONDARY ENDPOINTS

  • IONIS PHARMACEUTICALS INC - ZILGANERSEN SHOWS FAVORABLE SAFETY AND TOLERABILITY PROFILE

  • IONIS PHARMACEUTICALS INC: EVALUATING POTENTIAL TO INITIATE AN EXPANDED ACCESS PROGRAM (EAP) IN U.S.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI